Mark N. Lampert, Director: MoonLake Immunotherapeutics MLTX Sell · Filed 04/02

Trade details

Type: Insider sale
Amount: $26,345,457.64
Shares · price: 1,569,116 sh · $16.79 a share
Held after: 6,599,722 sh
Stock: MoonLake Immunotherapeutics MLTX
Person: Mark N. LampertDirector
Trade date: 26/03/31
Filed: 26/04/02
Days to filing: 2 days

Sold 19.2% of holdings

Share of holding sold: 19.2%

MoonLake Immunotherapeutics trades, last 26 weeks

What else happened in MoonLake Immunotherapeutics around then

Filed or reported within 30 days of the trade day · 03/01~04/30

Mark N. Lampert's recent trades

Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$89.2M
837,914 sh
$89.2M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$66.8M
627,597 sh
$66.8M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$12.1M
113,289 sh
$12.1M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$5.5M
51,858 sh
$5.5M
Filed 06/26
Traded 06/26
Mark N. LampertDirector
SellMoonLake Immunotherapeutics
Sell
MoonLake Immunotherapeutics
MLTX
$32.4M
1,932,354 sh
$32.4M
Filed 04/02
Traded 03/31

Mark N. Lampert, Director — sold $26.3M of MoonLake Immunotherapeutics MLTX · 19.2% of holdings | Whalegun